End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- CNY | -.--% | -.--% | -.--% |
25/04 | Intco Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
24/04 | Intco Medical Technology Co., Ltd. Proposes Final Dividend for 2023 | CI |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company appears to be poorly valued given its net asset value.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 2.45B | - | - | |
+9.48% | 27.38B | B+ | ||
-30.22% | 3.08B | B- | ||
-16.72% | 2.51B | C+ | ||
-3.32% | 2.05B | - | ||
+7.78% | 2.09B | B | ||
+2.22% | 1.55B | B | ||
+0.59% | 1.29B | - | ||
+23.24% | 1.23B | C | ||
+6.87% | 1.13B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300677 Stock
- Stock
- Ratings Intco Medical Technology Co., Ltd.